Cargando…
Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal
Clinical trials in humans are vital to test safety and efficacy of new interventions and are accompanied with the complexity of related regulatory guidelines, stringent time frame and financial burden particularly when participants are children. Conducting clinical trials in low and middle income co...
Autores principales: | Chapagain, Ram Hari, Maharjan, Jessica, Adhikari, Santosh, Thapa, Prabhat, Kunwar, Kshitij, Giri, Bishnu Rath, Shrestha, Nisha Jyoti, Shrestha, Anil Kumar, Shrestha, Sanjeet Kumar, Tamang, Suresh Man, Cho, Haeun, Park, Eun Lyeong, Lee, Jiyoung, Lee, Jinae, Kim, Deok Ryun, Yang, Jae Seung, Saluja, Tarun, Wartel, Anh, Lynch, Julia, Song, Katerina Rok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405748/ https://www.ncbi.nlm.nih.gov/pubmed/37539816 http://dx.doi.org/10.1080/21645515.2023.2239680 |
Ejemplares similares
-
Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal
por: Chapagain, Ram Hari, et al.
Publicado: (2022) -
Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013) -
Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011) -
China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022) -
Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)